Abbott Laboratories (NYSE: ABT) has reported earnings for its second fiscal quarter (ending June 30) of $0.74 versus $0.79 for the same period a year ago — a decline of -6%. This performance was $-0.37 […]
For its second fiscal quarter (ending June 30), Textron Inc (NYSE: TXT) has reported a 3% increase in E.P.S. from $1.31 a year ago to $1.35 in the current quarter. However, this result fell short […]
Texas Capital Bancshares Inc (NASDAQ: TCBI) has reported E.P.S. of $0.80 for its second fiscal quarter (ending June 30) versus $1.34 for the same period a year ago — a decline of -40%. This performance […]
For its second fiscal quarter (ending June 30), Southern First Bankshares Inc (NASDAQ: SFST) has reported a 19% increase in E.P.S. from $0.31 a year ago to $0.37 in the current quarter. This result exceeded […]
For its second fiscal quarter (ending June 30), Snap-On Inc (NYSE: SNA) has reported a 3% increase in E.P.S. from $4.98 a year ago to $5.15 in the current quarter. This result exceeded the consensus […]
For its second fiscal quarter (ending June 30), S&T Bancorp Inc (NASDAQ: STBA) has reported a 0% change in E.P.S. from $0.89 a year ago to $0.89 in the current quarter. This result exceeded the […]
On 7/18/24, Live Ventures Inc (NASDAQ: LIVE) stock suffered a major decline of -12.0%, closing at $18.01. Moreover, exceptionally high trading volume at 226% of normal accompanied the decline. Relative to the market the stock […]
Lipocine Inc (NASDAQ: LPCN) stock closed at $5.54 on 7/18/24 after a major decline of -13.2%. Moreover, this decline was accompanied by unusually high trading volume at 158% of normal. The stock has declined -26.6% […]
Recent notable negative changes in fundamentals have impacted Innoviva Inc (NASDAQ: INVA): the stock’s power rating fell below 50, significant quarterly sales deceleration occurred, and the consensus estimate for December, 2025 decreased significantly. Recent meaningful […]
For its third fiscal quarter (ending June 30), D.R. Horton Inc. (NYSE: DHI) has reported a 5% increase in E.P.S. from $3.93 a year ago to $4.12 in the current quarter. This performance was $0.33 […]
Privacy Statement Terms Of Use ©2024 PriceTarget Research